Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
Go back to Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1103.69 +5.12 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1112.24 | 52 Week Low | $67.88 | |||
| Day High | $1119.45 | P/E | 255.48 | |||
| Day Low | $1093.15 | EPS | $4.32 | |||
| Volume | 2,161,268 | |||||
